A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.

A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.

Jude Phillip, assistant professor in the Department of Biomedical Engineering, received an R35 MIRA award from the National Institutes of Health.

The same team of scientists also showed that KROS 101 increased the proliferation of helper and cytotoxic T cells (CD4+ and CD8+), while decreasing T reg cell growth in a melanoma model.

1Department of Pediatric Hematology and Oncology, Justus-Liebig University, Giessen, Germany. 2Department of Pathology, Boston Children´s Hospital, Boston, Massachusetts. 3Department of Pediatric ...

What are T cell engagers? This class of drugs has shot to fame in recent years because of their ability to harness the immune system. T cell engagers are antibodies that are engineered to recognize ...

"We must be at the same level, parents and teachers. Schools can't be prisons when homes are safe havens for misbehaving," Mr Tuzareirwe said. He was speaking during a thanksgiving ceremony at ...

Re “Why water systems aren’t designed for huge fires” (Feb. 10): The article by Tom Majich forgets two simple truths: 1) with adequate hydraulic pressure (read: full reservoirs), all fire ...

Porter has played a pivotal role in advancing the field, including pioneering work in CAR T-cell therapy. Dr. Porter has been deeply involved with ASTCT, previously serving as the Society's ...